Provided By PR Newswire
Last update: Jun 7, 2024
NEW YORK, June 7, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abeona Therapeutics Inc. ("Abeona" or the "Company") (NASDAQ: ABEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:ABEO (2/21/2025, 8:00:00 PM)
5.78
-0.04 (-0.69%)
Find more stocks in the Stock Screener